Jim Phillips

Alveda Pharmaceuticals, Inc. sells and distributes pharmaceuticals and medical devices. Its products are available in different sizes and formats including glass vials, ampoules, syringes, and polyampoules. The firm''s consulting services cover areas, such as, product development, warehousing and logistics, manufacturing, quality control testing and product analysis, and labeling and package development. It serves hospitals, buying groups, wholesalers, individual physicians, pharmacists, and patients. The company was founded in November 2006 and is headquartered in Toronto, Canada.

Canadian Animal Health Institute operates as the trade association representing the developers, manufacturers and distributors of animal pharmaceuticals, biologics, feed additives and animal pesticides. The firm serves in the animal health product market. The company is headquartered in Guelph, Canada.

BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun.

Part of DSM-Firmenich AG, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The private company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM-Firmenich AG from Province of Québec on July 13, 2005.

Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada.

National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe.

Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada.

Chartered Professional Accountants of Ontario engages in the provision of accounting education. It offers certification, continued trainings, and professional development. The company was founded in 2014 and is headquartered in Toronto, Canada.

adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.

The company's principal activity is to provide financial solutions to farm families and agribusiness. It provides visible support to rural Canada through various community investments. The company operates solely in Canada.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA.

Global Transplant Solutions, Inc. provides solutions for the preservation of human organs.

Lunenfeld-Tanenbaum Research Institute engages in the provision of biomedical research services. It conducts research into various forms of cancer including colon, breast, pancreatic, prostate, neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine, and systems biology. The company was founded in 1985 and is headquartered in Toronto, Canada.

Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.

Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland.